Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

GUIDENANO

Financiado

Cerrado

Assessment and mitigation of nano enabled product risks on human and environment...

Assessment and mitigation of nano enabled product risks on human and environmental health Development of new strategies and creation of a digital guidance tool for nanotech industries The main objective of GUIDEnano is to develop innovative methodologies to evaluate and manage human and environmental health risks of nano-enabled products, considering the whole product life cycle. A strategy to identify hot spot... ver más

30/04/2017

LEITAT

11M€

Presupuesto del proyecto: 11M€

Líder del proyecto

ACONDICIONAMIENTO TARRASENSE - LEITAT No se ha especificado una descripción o un objeto social para esta compañía.

TRL 2-3 | 51M€

Fecha límite participación Sin fecha límite de participación.

Ver 28 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2017-04-30 No tenemos la información de la convocatoria

0% 73% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

28 Participantes

LEITAT

0.00€ | Lider

ITENE

N.D. | Participante

UNEXE

N.D. | Participante

INOTEX

N.D. | Participante

Proyectos interesantes

GRACIOUS

Nanotechnology

Environmental S...

7M€ Cerrado

SAbyNA

Nanotechnology

Materials Scien...

6M€ Cerrado

NEPHH

Nanotechnology

Environmental S...

3M€ Cerrado

ENRHES

Nanotechnology

Environmental S...

280K€ Cerrado

NANEX

Nanotechnology

Environmental S...

1M€ Cerrado

NANOIMPACTNET

Nanotechnology

Medical Technol...

3M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

ACONDICIONAMIENTO TARRASENSE - LEITAT No se ha especificado una descripción o un objeto social para esta compañía.

TRL 2-3 | 51M€

Presupuesto del proyecto 11M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The main objective of GUIDEnano is to develop innovative methodologies to evaluate and manage human and environmental health risks of nano-enabled products, considering the whole product life cycle. A strategy to identify hot spots for release of nanomaterials (NMs) will be followed by decision trees to guide on the use of (computational) exposure models and, when necessary, design of cost-effective strategies for experimental exposure assessment. These will include on-site and off-site monitoring of industrial processes, use, accelerated aging, recycling and disposal set-ups. In all cases, there will be a strong emphasis on the transformation of NMs. Similarly, a tiered strategy to evaluate the environmental fate and the hazards for ecosystem and human health of NMs will be developed. The project will consider pristine synthesized NMs, transformed NMs released during the life cycle of the product, and interactions of the NMs with other substances in their host matrices and ubiquitous pollutants. The project will also develop innovative solutions to reduce identified risks. These will include safer-by-design approaches (to reduce NM hazard, reduce migration and release, or accelerate degradation when released), new technological solutions for exposure control measures, and solutions for waste minimization and treatment. These developments will be incorporated into an web-based Guidance Tool, which will guide the nano-enabled product developers (industry) into the design and application of the most appropriate risk assessment & mitigation strategy for a specific product. The correct implementation of this guidance will ensure that the risks associated to a nano-enabled product, throughout its whole life cycle, have been appropriately evaluated and mitigated to an acceptable level. This methodology will set up the basis for the certification (by an independent third party), as a risk communication tool addressed to regulators, insurance companies, and the society.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores